Exforge HCT is a combination of three different medications that are used to treat high blood pressure. It contains two different types of drugs, which are an angiotensin II receptor blocker (ARB) and a diuretic. The combination of these two medications helps to lower blood pressure more effectively than either medication alone. Exforge HCT has been approved by the U.S. Food and Drug Administration (FDA) and is available in both generic and brand-name forms. This article will provide a comprehensive guide to the benefits of Exforge HCT and how it can help to manage high blood pressure.
Exforge HCT is a combination of two different medications, amlodipine and valsartan. Amlodipine is a type of calcium channel blocker, which helps to relax blood vessels and reduce the amount of pressure that is put on them. Valsartan is an angiotensin II receptor blocker (ARB), which works to block the action of a hormone called angiotensin II. This hormone can cause the blood vessels to narrow, which can raise blood pressure. The third medication in Exforge HCT is hydrochlorothiazide, which is a diuretic. Diuretics help to reduce the amount of fluid in the body, which can reduce the amount of pressure on the blood vessels.
Exforge HCT works by combining the effects of the three medications. The amlodipine helps to relax the blood vessels, reducing the amount of pressure on them. The valsartan blocks the action of angiotensin II, which helps to keep the blood vessels from narrowing. The hydrochlorothiazide helps to reduce the amount of fluid in the body, which reduces the pressure on the blood vessels. All three medications work together to help lower blood pressure.
Exforge HCT can provide a number of benefits for those with high blood pressure. These benefits include:
Exforge HCT can cause a number of side effects, including:
Exforge HCT is not recommended for those with certain medical conditions, including:
1.
The Kansas Cancer Center awarded two Indian American doctors professorships.
2.
Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy
3.
The lack of psychiatrists may be addressed by community workers.
4.
Living near St. Louis-area Coldwater Creek during childhood linked with higher risk of cancer from radiation
5.
Immunotherapy and targeted radiation shrink liver tumors, enabling surgery
1.
Machine Learning in Hematology: Boosting Diagnostic Precision and Speed in Medical Practice
2.
Understanding Purpura Fulminans: Causes, Symptoms and Treatment Options
3.
Exploring the Latest Treatments for Essential Thrombocythemia
4.
Interplay of Brown Hair, Follicular Biology, and Hair Growth Inhibitors in Melanoma Pathogenesis
5.
The Role of Alanine Aminotransferase in Liver Health and Disease
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
2.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
3.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation